The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Feb. 06, 2007

Filed:

Feb. 24, 2005
Applicants:

Kevin X. Chen, Edison, NJ (US);

F. George Njoroge, Warren, NJ (US);

Mousumi Sannigrahi, Summit, NJ (US);

Latha G. Nair, Edison, NJ (US);

Weiying Yang, Edison, NJ (US);

Bancha Vibulbhan, Kenilworth, NJ (US);

Srikanth Venkatraman, Woodbridge, NJ (US);

Ashok Arasappan, Bridgewater, NJ (US);

Stephane L. Bogen, Somerset, NJ (US);

Frank Bennett, Cranford, NJ (US);

Viyyoor M. Girijavallabhan, Parsippany, NJ (US);

Inventors:

Kevin X. Chen, Edison, NJ (US);

F. George Njoroge, Warren, NJ (US);

Mousumi Sannigrahi, Summit, NJ (US);

Latha G. Nair, Edison, NJ (US);

Weiying Yang, Edison, NJ (US);

Bancha Vibulbhan, Kenilworth, NJ (US);

Srikanth Venkatraman, Woodbridge, NJ (US);

Ashok Arasappan, Bridgewater, NJ (US);

Stephane L. Bogen, Somerset, NJ (US);

Frank Bennett, Cranford, NJ (US);

Viyyoor M. Girijavallabhan, Parsippany, NJ (US);

Assignee:

Schering Corporation, Kenilworth, NJ (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/4035 (2006.01); A61K 31/403 (2006.01); A61K 31/407 (2006.01); A61K 31/454 (2006.01); A61K 31/5355 (2006.01); A61K 31/4725 (2006.01); A61K 31/4166 (2006.01); C07D 209/48 (2006.01); C07D 209/52 (2006.01); C07D 209/02 (2006.01); C07D 471/02 (2006.01); C07D 401/12 (2006.01); C07D 413/12 (2006.01); C07D 217/24 (2006.01); C07D 233/02 (2006.01); C07D 233/74 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention discloses novel compounds which have HCV protease inhibitory activity as well as methods for preparing such compounds. In another embodiment, the invention discloses pharmaceutical compositions comprising such compounds as well as methods of using them to treat disorders associated with the HCV protease.


Find Patent Forward Citations

Loading…